Control Bionics (ASX:CBL)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Control Bionics.
RELATED STOCKHEAD STORIES
Control Bionics’ growth bounces ahead
These ASX companies are stepping up to tackle traumatic brain injury head-on
Health Check: More, please! When record results are not good enough for expectant investors
Four ASX stocks seeking a competitive edge in the lucrative sports market
Road to 2025: Control Bionics’ breakout into sports science
Health Check: Clinical trials don’t sleigh down for the silly season
Strong growth boosts Control Bionics’ US revenue in H1 FY25
Control Bionics leaps into new US and Japanese markets with strategic deals
Biocurious: Armed with a lucky payment number, Control Bionics plots its US expansion
Closing Bell: Arcadium holders cash in, Oil rallies as Milton hits, and GYG keeps momentum going
Health Check: Control Bionics eyes 20pc revenue growth and ‘near term’ profitability
Closing Bell: Energy stocks cushion ASX’s mini crash; Infinity soars on Cangai copper acquisition
Control Bionics boosts revenue with faster NDIS approvals and new leasing program
